The TECNO (@tecno_trial) 's Twitter Profile
The TECNO

@tecno_trial

ID: 1509760380280746046

calendar_today01-04-2022 05:12:06

363 Tweet

159 Followers

80 Following

NeuroNews (@nn_publishing) 's Twitter Profile Photo

The "first" subanalysis from the Distal Trial is disclosed by Aikaterini Anastasiou, with results across 447 patients suggesting a higher proportion of brain tissue being saved in the study's EVT group compared to its best medical therapy group #esoc2025 European Stroke Org Marios Psychogios

The "first" subanalysis from the <a href="/DistalTrial/">Distal Trial</a> is disclosed by Aikaterini Anastasiou, with results across 447 patients suggesting a higher proportion of brain tissue being saved in the study's EVT group compared to its best medical therapy group
#esoc2025 <a href="/ESOstroke/">European Stroke Org</a> <a href="/MPeyT1/">Marios Psychogios</a>
European Stroke Org (@esostroke) 's Twitter Profile Photo

Essential reading for stroke specialists – the European Stroke Journal ICH Supplement From reversal strategies to post-ICH management—read the latest insights: 🔗 ow.ly/ZJ0s50VWrAC #ESOC2025 #StrokeCare #ICH #Neurology #VoiceOfStroke #StrokeTwitter

Essential reading for stroke specialists – the European Stroke Journal ICH Supplement 
From reversal strategies to post-ICH management—read the latest insights:

🔗 ow.ly/ZJ0s50VWrAC

#ESOC2025 #StrokeCare #ICH #Neurology #VoiceOfStroke #StrokeTwitter
Stroke Research Center Bern (@strokebern) 's Twitter Profile Photo

Thank you to Professor Mitchell Elkind for an inspiring Cardio-Neuro lecture Stroke Research Center Bern on #atrial #cardiopathy! A brilliant overview of its role in stroke risk—and a call to rethink traditional paradigms. We're grateful for your insights and leadership in the field. 🫀🧠🙏🫶

Thank you to Professor <a href="/MitchElkind/">Mitchell Elkind</a> for an inspiring Cardio-Neuro lecture <a href="/StrokeBern/">Stroke Research Center Bern</a> on #atrial #cardiopathy! A brilliant overview of its role in stroke risk—and a call to rethink traditional paradigms. We're grateful for your insights and leadership in the field. 
🫀🧠🙏🫶
David Seiffge (@davidseiffge) 's Twitter Profile Photo

News from the Swiss Stroke Registry by ⁦Martina Göldlin: DWI-lesions in ICH are frequent, already on admission before any intervention; associationbwith CAA and SVD burden. Suitable surrogate outcome in trials?Stroke Research Center Bern⁩ ⁦Neurology Journal⁩ neurology.org/doi/10.1212/WN…

European Stroke Org (@esostroke) 's Twitter Profile Photo

Urs Martin Fischer presenting Distal Trial Medium Vessel Occlusion Trial and #discount trial which showed that #EVT did not improve the modifiable risk. More evidence and #stroketrials are needed. #stroketreatment #strokecare #EAN2025

<a href="/FishingNeurons/">Urs Martin Fischer</a> presenting <a href="/DistalTrial/">Distal Trial</a> <a href="/MeVOTrial/">Medium Vessel Occlusion Trial</a> and #discount trial which showed that #EVT did not improve the modifiable risk. 

More evidence and #stroketrials are needed. 

#stroketreatment #strokecare #EAN2025
Elena Becker-Barroso (@beckerbarroso) 's Twitter Profile Photo

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST) - The Lancet thelancet.com/journals/lance…

Stroke Research Center Bern (@strokebern) 's Twitter Profile Photo

🚨 New in The Lancet: The CATALYST meta-analysis refines when to start anticoagulation after ischaemic stroke in #AF patients. Proud to see major contribution from Stroke Research Center Bern driving international stroke research forward! 🧠 sciencedirect.com/science/articl… Urs Martin Fischer UCL Stroke Research

The TECNO (@tecno_trial) 's Twitter Profile Photo

🚨 Milestone reached 🚨 We have officially enrolled 50% of the patients in the #TECNO study 💿 Huge thanks to all participating centers, coordinators, and teams for your dedication and teamwork 🙏

🚨 Milestone reached 🚨

We have officially enrolled 50% of the patients in the #TECNO study 💿

Huge thanks to all participating centers, coordinators, and teams for your dedication and teamwork 🙏
Insel Gruppe (@inselgruppe) 's Twitter Profile Photo

Internationale Studie zeigt: Frühzeitige Blutverdünnung nach Schlaganfall ist sicher & wirksam. Patient:innen mit Vorhofflimmern profitieren deutlich – 30 % weniger Folge-Schlaganfälle. Mehr: neurologie.insel.ch/de/aktuelles/d… #InselGruppe #Schlaganfall #Neurologie Urs Martin Fischer

Internationale Studie zeigt: Frühzeitige Blutverdünnung nach Schlaganfall ist sicher &amp; wirksam. Patient:innen mit Vorhofflimmern profitieren deutlich – 30 % weniger Folge-Schlaganfälle. Mehr: neurologie.insel.ch/de/aktuelles/d…

#InselGruppe #Schlaganfall #Neurologie
 
<a href="/FishingNeurons/">Urs Martin Fischer</a>
Insel Gruppe (@inselgruppe) 's Twitter Profile Photo

International study confirms early blood thinner treatment post-stroke is safe & effective. Patients with atrial fibrillation benefit – 30% fewer recurrent strokes. More: thelancet.com/journals/lance… #InselGruppe #Stroke #Neurology Urs Martin Fischer

International study confirms early blood thinner treatment post-stroke is safe &amp; effective. Patients with atrial fibrillation benefit – 30% fewer recurrent strokes. More: thelancet.com/journals/lance…

#InselGruppe #Stroke #Neurology
 
<a href="/FishingNeurons/">Urs Martin Fischer</a>
Urs Martin Fischer (@fishingneurons) 's Twitter Profile Photo

Many thanks to all the CATALYST collaborators, who helped us to solve this old dilemma in acute stroke management: there is no reason to delay anticoagulants in ischemic stoke patients with atrial fibrillation! Insel Gruppe Stroke Research Center Bern Universität Bern